EATON VANCE MANAGEMENT - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
EATON VANCE MANAGEMENT ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$2,561,000
-5.3%
237,1550.0%0.00%0.0%
Q2 2022$2,704,000
+25.2%
237,1550.0%0.00%
+100.0%
Q1 2022$2,160,000
-38.9%
237,1550.0%0.00%
-50.0%
Q4 2021$3,538,000
-42.0%
237,1550.0%0.00%
-50.0%
Q3 2021$6,095,000
-1.5%
237,1550.0%0.01%0.0%
Q2 2021$6,185,000
-26.2%
237,155
-0.1%
0.01%
-33.3%
Q1 2021$8,379,000
-30.0%
237,353
-50.0%
0.01%
+33.3%
Q4 2020$11,972,000
+33.9%
474,310
+100.0%
0.01%
-43.8%
Q3 2020$8,943,000
-11.9%
237,1550.0%0.02%
-23.8%
Q2 2020$10,155,000
+120.3%
237,1550.0%0.02%
+90.9%
Q1 2020$4,610,000237,1550.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders